OR WAIT null SECS
September 18, 2020
The agency’s human medicines committee is endorsing the use of dexamethasone in COVID-19 patients requiring oxygen therapy.
The EMA recommendations include a meningococcal vaccine and the biosimilar Nyvepria.
September 15, 2020
GenSight Biologics has submitted a marketing authorization application to the European Medicines Agency for Lumevoq.
September 09, 2020
Imfinzi has been granted approval in the EU for the treatment of adults with extensive-stage small cell lung cancer.
September 02, 2020
Despite pharmacovigilance legislation being in place for nearly a decade, many companies are still struggling to fulfill obligations.
The 2020–2025 EMRN strategy will be regularly reviewed over the coming five years to accommodate science and technology advances.
The agency is reviewing an application for Dexamethasone Taw for treating adult patients with COVID-19.
August 20, 2020
The UK's MHRA will resume on-site risk based GxP inspections from September 2020.
August 07, 2020
The European Medicines Agency recently approved two European Novartis sites in France and Switzerland for the commercial manufacturing of chimeric antigen receptor T-cell cell therapies.
August 02, 2020
EU regulators are requesting more effective action be taken to tackle serious impurities in APIs and finished products.